Xenon in MRI OK for COPD Patients
Inhaling undiluted, hyperpolarized xenon 129 for magnetic resonance imaging of the lungs is safe for chronic obstructive pulmonary disease (COPD) patients as well as healthy volunteers, Duke University researchers reported online on Nov. 4 in the journal Radiology.
Inhaling undiluted, hyperpolarized xenon 129 for magnetic resonance imaging of the lungs is safe for chronic obstructive pulmonary disease (COPD) patients as well as healthy volunteers, Duke University researchers reported online on Nov. 4 in the journal Radiology.
The team led by Bastiaan Driehuys, PhD, tested 24 healthy volunteers, 10 COPD patients, and 10 age-matched control subjects. All 44 subjects received three or four one-liter volumes of undiluted hyperpolarized xenon-129 followed by a breath-hold of up to 16 seconds for MR imaging. Researchers tracked oxygen saturation, heart rate and rhythm and blood pressure, in addition to respiratory rate and subjective symptoms. Subjects’ serum biochemistry and hematology, as well as echocardiograms, were recorded at the time of screening and 24 hours later; echocardiograms were done two hours prior and an hour after imaging, as well.
Driehuys and colleagues found that, while subjects did briefly experience mild symptoms associated with xenon’s anesthetic properties, hyperpolarized xenon-129 was well tolerated in healthy subjects as well as those with mild to moderate COPD.
FDA Clears Virtually Helium-Free 1.5T MRI System from Siemens Healthineers
June 26th 2025Offering a cost- and resource-saving DryCool magnet technology, the Magnetom Flow.Ace MRI system reportedly requires 0.7 liters of liquid helium for cooling over the lifetime of the device in contrast to over 1,000 liters commonly utilized with conventional MRI platforms.
Multinational Study Reaffirms Value of Adjunctive AI for Prostate MRI
June 16th 2025The use of adjunctive AI in biparametric prostate MRI exams led to 3.3 percent and 3.4 percent increases in the AUC and specificity, respectively, for clinically significant prostate cancer (csPCa) in a 360-person cohort drawn from 53 facilities.
Study: AI-Generated ADC Maps from MRI More Than Double Specificity in Prostate Cancer Detection
June 5th 2025Emerging research showed that AI-generated ADC mapping from MRI led to significant increases in accuracy, PPV and specificity in comparison to conventional ADC mapping while achieving a 93 percent sensitivity for PCa.
